PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 183 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $2,145,000 | +47.7% | 46,992 | +21.5% | 0.09% | +48.3% |
Q3 2017 | $1,452,000 | -21.3% | 38,675 | 0.0% | 0.06% | -24.7% |
Q2 2017 | $1,845,000 | +4.6% | 38,675 | 0.0% | 0.08% | +1.3% |
Q1 2017 | $1,764,000 | -90.2% | 38,675 | -92.7% | 0.08% | -87.8% |
Q2 2016 | $17,942,000 | -67.5% | 531,944 | -49.0% | 0.62% | -61.9% |
Q1 2016 | $55,275,000 | -54.5% | 1,043,311 | -34.0% | 1.64% | -23.8% |
Q4 2015 | $121,382,000 | +19.5% | 1,580,699 | -36.0% | 2.15% | +102.8% |
Q3 2015 | $101,539,000 | -37.0% | 2,470,540 | +8.5% | 1.06% | -25.7% |
Q2 2015 | $161,099,000 | -6.8% | 2,277,980 | +17.0% | 1.42% | -2.5% |
Q1 2015 | $172,919,000 | +16.4% | 1,946,192 | +16.1% | 1.46% | +22.3% |
Q4 2014 | $148,566,000 | +1.7% | 1,675,686 | +11.2% | 1.19% | +4.5% |
Q3 2014 | $146,057,000 | +47.7% | 1,506,985 | +40.0% | 1.14% | +59.3% |
Q2 2014 | $98,877,000 | +50.0% | 1,076,384 | +14.3% | 0.72% | +50.6% |
Q1 2014 | $65,939,000 | +361.3% | 942,126 | +278.9% | 0.48% | +371.3% |
Q4 2013 | $14,294,000 | +1219.9% | 248,640 | +1003.6% | 0.10% | +1162.5% |
Q3 2013 | $1,083,000 | – | 22,530 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |